The company - ExAller®



Acar’Up Consumer Health is a belgian healthcare company headquartered in Brussels.
Scientific researchers at the Brussels universities ULB and UCL have studied for many years the dust mites, their behaviour and the pheromones that they release. Based on the learnings, they have developed an innovative product that attracts the dust mites. By spraying the solution on a textile, the dust mites could be trapped and eliminated.

In a clinical study, the trapping device was used on the mattress of dust mite allergic children to make the mattress “dust mite free”. It has been demonstrated that a strong majority of the severe allergic children did have a significant decrease of their allergic symptoms already after a first use. This study enabled the company to obtain the autorization to market the product in the EU and indicated to relief allergic symptoms among dust mite allergic people.

Acar’Up Consumer Health owns the worldwide exclusive rights on this innovation.

The product was launched under the Acar’Up brand name in Belgium in 2014 and became in record time the first-line prescription therapy by allergy specialists. Year-on-year a growing number of allergic people have started to use Acar’Up to prevent having allergic symptoms.
In 2017, the Board of Directors decided to launch the product in a high number of countries around the world. Several venture capital funds joined a capital increase operation to provide the necessary funding and a new CEO with over 20 years of international experience in marketing consumer health products was hired.

Outside Belgium, the product is being marketed under the ExAller brand name.


To become the global leader in prevention and treatment of allergic symptoms caused by dust mites.


Mr. Edouard Croufer*

Edouard Croufer held several leading positions in the pharmaceutical and chemical industry. Among those, he has been General Director of UCB pharma division and UCB chemicals division. Currently he is board member in several companies as well as Vice President of the Belgian Red Cross.

*Edouard Croufer representing MepCro sprl

Mr. Laurent Jouret

Laurent Jouret has joined Investures SA in 2017 as Senior Investment Manager & Head of Corporate services. Prior to joining Inventures, Laurent was Senior Investment Manager at Sofina. He was a member of the internal committee overseeing the direct investment opportunities and has represented Sofina as a non-executive director in portfolio companies. He previously held various positions at leading financial institutions such as ING and Citibank.

Innovation Fund represented by Edith Coune

The Innovation Fund has been created in February 2015. The fund invests in innovative startups and companies active in the field of chemistry and life sciences. With the Innovation Circle and Fund, essenscia and François Cornelis have created a one-stop shop for creative and innovative companies in the Belgian sector of chemistry.

Edith Coune has more than 20 years of experience in the chemical industry. Among others, she held the position of Communication Manager at BASF. Edith is the General Secretary of the Innovation Circle and the Innovation Fund since their creation.

Mike Van Ganse

Mike Van Ganse has over 25 years of international experience in the consumer health industry. For over 15 years he worked for some of the leading global consumer health companies such as Novartis and Bayer in Europe and USA.  In 2009 he was founder of a start-up consumer health company that launched an innovative product in the treatment of nail fungus under the brand name Excilor. After 4 years, the brand was successfully launched in over 15 countries worldwide, before it was sold to Vemedia.

Inventures S.A. represented by Mr. Bruno de Radzitzky

Inventures is a European venture capital fund that builds a better world by investing in fast growing companies and sustainable businesses led by ambitious and visionary founders.

Bruno de Radzitzky has almost 25 years experience in M&A transactions. He started his career as a lawyer, member of the Brussels Bar. He then joined Etex (a Belgian group active in building materials around the world) as a Company Lawyer, and then as Senior Legal Counsel. He joined Inventures on January 1st 2017 as Head of Asset Management.

Theodorus III S.A. represented by Mr.Lotfi Yelles

Theodorus is the spin-off investment fund of the Université Libre de Bruxelles (ULB). Its primary mission is to finance companies created based on innovative technologies developed within or in collaboration with the university.

Lotfi Yelles joined Thedorus Investment Funds as Partner in 2017.  Prior to joining Theodorus, Lotfi worked at McKinsey & Company as an Engagement Manager where he primarily served the Pharma, Biotech & Medtech industries on a wide range of topics. He holds a Master degree in Aerospace Engineering (M.Eng.) and Business Engineering from ISAE-Supaero, in France.

Brustart S.A. represented by Mathilde Levy

Brustart, a subsidiary of SRIB Group, is a venture capital company dedicated to young Brussels companies. It has been created in December 1992 at the initiative of the Brussels-Capital Region Government.

Mathilde Levy joined SRIB in 2018. She currently holds the position of Investment Manager. As part of his work at brustart, Mathilde is a board member in several Brussels companies.


Mike Van Ganse*

Chief Executive Officer

*Mike Van Ganse representing MMVD GCV

Dorian Penninckx